Prostrakan to acquire distressed assets

Scotland-headquartered pharmaceutical firm Prostrakan has drawn down £5 million from an agreed £50 million loan facility to snap up distressed assets

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses. More by Marc Barber

Prostrakan to acquire distressed assets

Marc Barber

Related Stories

General Election 2024 – what do scale-ups want to see?

ThinCats to back high-growth companies with £300m fund

Fastest-growing companies in the UK revealed

Litestream Ventures unveils plans for ‘click-to-invest’ TV series

Related Topics